OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

Mr
I C Martin		 Chair
Dr D G Mason Honorary Treasurer (Demitted 10w November 2022)
Associate Professor PI Greaves Honorary Treasurer
Mrs 1 Barber
Professor Ti Hendra Demitted 10u November 2022
Professor Sir 8Keogh
Professor
N Kumar
Dr 5 Ushman CBE
Professor M Sani
The Trust ees have ma de the following
professional
appointments:
Solicitor; H Montlake
&Co, 198High Street, llford, Essex IG11'
Auditor: Kreston Reeves, Montague
Place, Quayside,
Chatham
Maritime,
Chatham,
ME4 4QU
Bankers: CAF Bank Limited, 25 Kings Hill Avenue,
Kings Hill, West Mailing, Kent ME1941Q
CCLA Investment
Management
Limited, 80Cheapside,
London
EC2V 6DZ
Virgin Money, iubilee House, Gosforth, Newcastle
upon Tyne, NE34PL
'The Charity Bank Umited,
Fosse House, 182High Street, Tonbrldge,
TN9 1BE
Nationwide
Building Society, Nationwide
I-louse, Pipers Way, Swindon,
SN38 1NW
Stockbrokers: Quilter Cheviot Investment
Management,
Senator House, 85 Queen Victoria St, London		 EC4V
4AB
Insurance Brokers: Insurance
Services (Surrey) Ltd, PO Box1533,Woking, GU22 2RY
Secondslght,
Foster Denovo Group, 2 Hamm Moor lane, Weybridge,
Surrey KT15 2SA
The following key senior members ofstaff are responsible
for the day-to-day
activities ofthe charity who together		 with
the Trustees form the key management
personnel ofthe charity:

Association ofAnaesthetlsts Royal College ofNursing
Dr W Fawcett Dr N Ashby
Association ofSurgeons of Great Britain and Ireland Royal College ofObstetricians and Gynaecologists
Mr M Lansdown Dr T Hillard
Royal College ofEmergency Medicine Royal College of Paedlatrics and Child Health
Dr A Boyle -demltted
10'"November		 2022 Drl Doughty
Katherine Henderson-appointed
10u November		 2022
Faculty ofDental Surgery Royal College ofPhysicians ofLondon
Mri Dhanda
Faculty ofIntensive
Care Medicine '		 Dr A Gibson,
Royal College		 Dr M Kumwenda
ofPsychiatrists		 and Dr H Skene
DrI Butler —demltted
20u June 2022		 DrJohnathan Richardson —appointed 10u November
Dr Dhruv Parek —appointed 31"January 2023 2022
Lay Representatives Royal College ofRadiologlsts
Vacancy Prof R McWilliams
Royal College ofAnaesthetists Royal College ofPathologists
Dr C Carey Dr L Igall —demltted
28'"April		 2022
Dr K Ramachandaran
—demitted
28u		 April 2022
Dr Barbara Bahlmann —appointed
1(F"November		 2022
Dr Subash Siv-appointed
10u November		 2022
Royal College of General Practitioners Royal College ofSurgeons ofEngland
DrCatherine
Mllllngton-Sanders
—appointed		 10u Miss 5Vlg
November
2022

Coroners' Society of England and Wales Dr DSharpstone
Healthcare
Quality Improvement
Partnership		 Mr M Skrypak
Healthcare
Quality Improvement
Partnership		 Mr D Smith
Healthcare
Quality Improvement
Partnership		 Mrs V Dunne
Royal College of Physicians
and Surgeons ofGlasgow		 Dr G Curry
Royal College of Physicians of Edinburgh Dr J MacLeod
Royal College ofSurgeons of Edinburgh Miss A Paisley
Dr A Goodwin Anaesthesia
and Critical Care
Dr M Juniper Respiratory
Medicine
Dr K Malbon Paediatrics
Dr S McPherson Radiology
Dr D McWilllams Physiotherapy
Dr A Michalskl Paediatric Oncology
Mr M Sinclair General Surgery
Dr VSrivastava Acute Medicine
Dr A Tavare General Practice
Mr IAberuombie Colorectal Surgery

1.Form the Study Advisory Group (SAG) 6.Advertise for reviewers 11.Run reviewer meetings
2.Undertake
su
/focus		 rou 7.Test data cogectlon methods 12.Data ana
sls
3.Write the
rotocol		 8.Meet with the SAG fora second time 13.Write the re ort
4. Desi
n the
uestlonnaires		 9.Final protocol toSteering Grou and HQIP 14.De
n the re ort
S.Advertise the stud 10.Start data collection 16.Pubgsh the re on

Area ofstudy: Milestone reached:
Transition
between		 chgd and adult healthcare Due for publication BuJune 23
Crohn's disease Due for publication lge July 23
Commun
ac		 aired neumonia Data being analysed
Testicular torsion Data collection underwa
Endometriosis Data collection underway
End of life care Data collection underway
Natural deaths In risen Data collection underwa
Juvenile arthritis Data collection underway
Rehabilitation following critical illness Stu
being develo		 ed
Blood sodium Stu
bein
develo		 ed
New 1 To be chosen
New 2 To be chosen
New 3 To be chosen

Total Total
Notes 2023 2022
E E
INCOME FROM:
Donations 202,320 132,900
Charitable
activities		 1,242,245 1,243,871
Investments 15,367 6,741
TOTAL INCOME 1,459,932 1,383,512
EXPENDITURE ON:
Charitable
activities		 1,443,417 1,216,165
TOTAL EXPENDITURE 1,443,417 1,216,165
Net loss/ gain on investments (19,051) 11,311
NET EXPENDITURE / INCOME (2,536) 178,658
NET MOVEMENT
IN FUNDS		 (2,536) 178,658
RECONCILIATION
OF FUNDS
Fund balances brought forward
at 1April 2022 1,694,229 1,515,571
FUND BALANCES CARRIED FORWARD
AT31MARCH 2023 1,691,692 1,694,229

Notes 2023 2022
E 6
FIXED ASSETS
Tangible assets 7,530 838
Investments 204,798 223,849
212,328 224,687
CURRENT ASSETS
Debtors 366,213 376,339
Cash at bank and ln hand 1,174,480 1,264,869
1,540,693 1,641,208
LIABILITIES
Creditors: Amounts falling due within one year 10 (31,329) (171,666)
NET CURRENT ASSETS 1,509,364 1,469,542
TOTAL ASSETS LESS CURRENT LIABILITIES 1,721,692 1,694+29
Provisions for liabilities (30,000)
TOTAL NET ASSETS 1,691,692 1,694,229
THE FUNDS OF THE CHARITY
Unrestricted
Income funds
GeneralFund 1,691,692 1,664,229
Designated
Premises		 Fund 30,000
TOTAL CHARITY FUNDS 1,691,692 1,694,229

Notes 2023 2022
E E
Cash flows from ope rating activities
Net cash provided
by operating		 activities 13 (96,119) 167,023
Cash flows from Investing activities
Interest from Investments 15,367 6,741
Purchase oftangible Rxed assets (9,637) (504)
Receipts from sale ofinvestments
Purchase ofinvestments
Net cash (outflow) inflow from investing activities 3,730 6,237
Increase (decrease) ln cash for the year (90,389) 173,260
Cash brought forward 1,264,869 1,091,609
Cash canted forward
1,174,480 1,264,869

Total Total
2023 2022
6 6
1. DONATIONS:
Donated services 202,320 132„E}00
202,320 132300
INCOME FROM CHARITABLE ACTIVITIES —DESIGNING AND RUNNING CONFIDENTIAL SURVEY
Healthcare
Quality Improvement		 1,205,122 1,207,221
Partnership
(HQIP)
Private hospitals 31,000 30,650
Conference,
exhibition		 and other
income sources 6,123 6,000
1,242,245 1,243,871
INVESTMENT INCOME
Dividends 6,752 6,079
Bank interest receivable on
short term cash deposits 8,615 662
15,367 6,741

Total Total
2023 2022
E E
Support costs (note 5) 304,090 241369
Direct staff costs (note 6) 658,335 574,354
Other direct expenditure:
Staff healthcare,
training,		 and recruitment 2,083 2,337
Clinical co-ordinators
secondments		 161,092 217,746
Clinical reviewers
(donated services)		 202,320 132,900
Clinical co-ordinators,
reviewers,		 and
staff expenses 52,574 14,757
Consultancy 2,476 13,235
Temporary
staff costs		 35,632 4,696
Conference, exhibition,
and meetings
expenses 7,618 371
Operating
lease rentals:
Plant and machinery 2,863 7,247
Other printing
and report		 production costs 7,361 4,782
Postage and distribution 7,666 2,371
1,443,417 1,216,165
Support Governance Total Total
costs costs 2023 2022
E 6 E E
SUPPORT AND GOVERNANCE COSTS
Staff costs (note 6) 873 873 746
Otherexpendlture:
Operating
lease rentals:
Land and buildings 141,437 141,437 133,644
Other premises costs 28,218 28,218 22,521
Auditors'
remuneration:
Audit fees 8,774 8,774 8,100
Bookkeeping and payroll costs 9,700 14 9,714 9,366
Public relations -60 -60 860
Computer
expenses		 27,127 38 27,165 21,951
Insurance 24,142 34 24,176 20,592
Sundry expenses 5,338 8 5,346 6,065
Telephone 4,627 7 4,634 4,748
Office costs 17,674 25 17,699 8,947
Steering Group expenses 1,378 4 1,383 681
Trustee expenses 1,708 1,708
Depredation
-owned assets		 2,941 2,945 2,958
Bank charges 79 79 190
Dilapidation
provisions		 30,000 30,000
294,309 9,781 304,090 241,369
PRIOR YEAR COMPARATIVE
Support Governance Total Total
costs costs 2022 2021
E E 6 6
SUPPORT AND GOVERNANCE COSTS
Staff costs (note 6) 746 746 691
Other expenditure:
Operating
lease rentals:
Land and buildings 133,644 133,644 136,747
Other premises costs 22,521 22,521 15,854
Auditors'
remuneration:
Audit fees 8,100 8,100 10,288
Bookkeeping and payroll costs 9,352 14 9,366 11,086
Public relations 859 1 860 454
Computer
expenses		 21,919 32 21,951 31,127
Insurance 20,562 30 20,592 17,635
Sundry expenses 6,054 11 6,065 4,247
Telephone 4,741 7 4,748 4,536
Office costs 8,933 14 8,947 5,400
Steering Group 680 1 681
Trustee expenses
Depreciation
—owned assets		 2,954 4 2,958 5,934
Bank charges 190 190 143
232,410 8,959 241,369 244,142

2023 2022
STAFF COSTS
No. No.
The average monthly
number ofpersons employed		 by
NCEPOD during the year (exduding Trustees) was:
Designing
and running ofconRdentlal		 surveys 16 14
Staff costs for the above persons:
Wages and salaries 544,319 480526
Social security costs 62,246 47,322
Pension costs 51,770 47,252
658,335 575,100
Staff costs are allocated
In the financial		 statements, as follows:
Designing
and running ofconRdentlal		 surveys —unrestricted 657,642 574354
Governance
costs		 873 746
658,335 575,100

Computer Fixtures &
equipment fittings TOTAL
E E E
Cost:
1April 2022 17,112 15,033 32,145
Additions 2,024 7,613 9,637
Disposals (15,034) (15,034)
31March 2022 19,136 7,612 26,748
Depreciation:
1Aprll2022 16,274 15,033 31,308
Charge
ln the year		 1,422 1,523 2,945
Depreciation
on disposal		 (15,034) (15,034)
31March 2023 17,696 1,522 (19,218)
Net book value:
31March 2023 1,440 6,090 7,530
31March 2022 838 838
2023 2022
INVESTMENTS
Usted investments:
Opening
balance at 1April		 223,849 212,538
Additions at cost
(inc cash account movement)
Dlsposals
Realised gains/losses In investments
Unreallsed
losses/gains		 on Investments (19,051) 11,311
Market value at 31March 204,798 223,849

2023 2022
Analysis ofinvestment holdings
QC Global income and Growth Fund 204,798 223,849
Market value at31March 204,798 223,849
DEBTORS
Amounts
falgng due within one		 year:
Trade debtors 290,439 304,871
Other debtors 24,643 24,643
Prepayments 51,131 46,825
366,213 376339
10. CREDITORS
Amounts
falling due within one		 year.
Trade creditors 6,862 7,752
Accruals and deferred income 24,467 163,914
31,328 171,666
Deferred income
Deferred Income at 1April 2022 110,000 88,000
Resources deferred
during the year		 22,000
Amounts
released from previous years		 (110,000)
110,000

1April Income Expenditure Loss on Transfers 31March
2022 Investment 2023
E E E E
Unrestricted Income funds:
General Fund 1,664,229 1,459,932 (1,443,417) (19,051) 30,000 1,691,692
Designated 30,000 (30,000)
Premises Fund
1,694,229 1,459,932 (1,443,417) (9,051) 1,691,692
1April Income Expenditure Loss on Transfer 31March
2021 Investment 2022
E E E
Unrestricted Income funds:
General Fund 1,495,571 1,383,512 (1,216,165) 11,311 (10,000) 1,664,229
Designated 20,000 10,000 30,000
Premises Fund
1,515,571 1,383,512 (1,216,165) 11,311 1,710,424 1,694,229

Fixed asset Tangible fixed Net current Total
Investments assets assets
6 E E
Unrestricted income funds:
General
Fund		 204,798 7,530 1,479,364 1,691,692
Designated Premises Fund
NET ASSETS AT31MARCH 2023 204,798 7,530 1,479,364 1,691,692
Fixed asset Tangible fixed Net current Total
investments assets assets
E 6 E
Unrestricted income funds:
General
Fund		 223,849 838 1,439,542 1,664,229
Designated Premises Fund 30,000 30,000
NET ASSETS AT31MARCH 2022 223,849 838 1,469,542 1,694,229

2023 2022
E E
Net Income forthe year (2,536) 178,659
Depreciation
(note		 7) 2,945 2959
Loss on Investments 19,051 (11,311)
Interest from Investment (15,367) (6,741)
Decrease (Increase) In debtors 10,126 (20,582)
(Decrease) increase in creditors (110337) 24,039
Net cash from operating activities (96,119) 167,023

2023 2022
land & Building Equipment Land & Building Equipment
Within 1year 6144,904 E5,606 E69,323 E5,606
Within 2-5 years 217,356 E15,418 622,424
Total 6362360 E21,024 E69,323 628,030
15. NET DEBTRECONCIUATION
At1April 2022 Cash flows At31March 2023
E E E
Cash at bank and in hand 1,264,869 (90,389) 1,174,480
Debt
Total 1,264,869 (90,389) 1,174,480
16. ANALYSIS OF CASH AND CASH EQUIVALENTS
2023 2022
E E
Cash ln hand 1,174,480 1,264,869
Total cash and cash equivalents 1,174,480 1,264,869